Novoneuron, Inc.
Records under this name other than patents Novoneuron, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Novoneuron, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,754,710 | Noribogaine in the treatment of pain and drug addiction Formerly held Term ended Term ended Mar 21, 2019 · From the USPTO record | Term ended | Term ended Mar 21, 2019 | From the USPTO record |
| US 8,178,524 | Noribogaine in the treatment of pain and drug addiction Formerly held Term ended Ended no later than Sep 3, 2018 · From the USPTO record | Term ended | Ended no later than Sep 3, 2018 | From the USPTO record |
| US 7,220,737 | Noribogaine in the treatment of pain and drug addiction Formerly held Lapsed on the fee record Ended May 22, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2015 | From the USPTO record |
| US 6,348,456 | Method of treating chemical dependency in mammals and a composition therefor Formerly held Term ended Term ended Feb 1, 2015 · From the USPTO record | Term ended | Term ended Feb 1, 2015 | From the USPTO record |
| US 5,591,738 | Method of treating chemical dependency using .beta.-carboline alkaloids, derivatives and salts thereof Term ended Term ended no later than Jan 7, 2017 · Low confidence | Term ended | Term ended no later than Jan 7, 2017 | Low confidence |